BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 15765304)

  • 1. [Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder].
    Wiedmann M; Schoppmeyer K; Witzigmann H; Hauss J; Mössner J; Caca K
    Z Gastroenterol; 2005 Mar; 43(3):305-15. PubMed ID: 15765304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of ultrasound in diagnosis of bile duct tumors].
    Höring E; Künzig B; von Gaisberg U
    Ultraschall Med; 1993 Dec; 14(6):269-71. PubMed ID: 8128209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of Klatskin tumours (hilar cholangiocarcinomas): comparison of MR cholangiography, MR imaging, and endoscopic retrograde cholangiography.
    Vogl TJ; Schwarz WO; Heller M; Herzog C; Zangos S; Hintze RE; Neuhaus P; Hammerstingl RM
    Eur Radiol; 2006 Oct; 16(10):2317-25. PubMed ID: 16622690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of endoscopic aspiration cytology and endoscopic retrograde cholangio-pancreatography in patients with cancer of the hepato-biliary tract. Part II.
    Harada H; Sasaki T; Yamamoto N; Tanaka J; Tomiyama Y
    Gastroenterol Jpn; 1977; 12(1):59-64. PubMed ID: 863180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interdisciplinary diagnosis of and therapy for cholangiocarcinoma].
    Kolligs FT; Zech CJ; Schönberg SO; Schirra J; Thasler W; Graeb C; Beuers U; Wilkowski R; Jacobs T; Böck S; Berster J; Heinemann V; Schäfer C
    Z Gastroenterol; 2008 Jan; 46(1):58-68. PubMed ID: 18188818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Percutaneous treatment of hilar cholangiocarcinoma completed by high-dose rate brachytherapy. Experience in the first 5 cases].
    Righi D; Maass J; Zanon E; Tettoni S; Orecchia R; Lazzari R; Ragona R; Gandini G
    Radiol Med; 1994; 88(1-2):79-85. PubMed ID: 7520594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Surgical therapy of proximal extrahepatic bile duct tumors (Klatskin tumors)].
    Timm S; Gassel HJ; Thiede A
    Zentralbl Chir; 2007 Aug; 132(4):328-35. PubMed ID: 17724636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic imaging of hilar cholangiocarcinoma: preoperative evaluation of ERC, MRC and PTC in comparison with histopathology].
    Romaneehsen B; Otto G; Lohse AW; Bittinger F; Herber S; Oberholzer K; Pitton MB; Thelen M
    Rofo; 2004 Dec; 176(12):1750-8. PubMed ID: 15573285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies.
    Vollmer CM; Drebin JA; Middleton WD; Teefey SA; Linehan DC; Soper NJ; Eagon CJ; Strasberg SM
    Ann Surg; 2002 Jan; 235(1):1-7. PubMed ID: 11753036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obstructive jaundice: harmless stone or malignant tumour? Diagnosis and management from a gastroenterologist's perspective].
    Schäfer C; Zech CJ; Göke B
    MMW Fortschr Med; 2009 Dec; 151(49-50):33-6. PubMed ID: 20085073
    [No Abstract]   [Full Text] [Related]  

  • 12. A modern approach to malignant hilar biliary obstruction.
    Freeman ML; Sielaff TD
    Rev Gastroenterol Disord; 2003; 3(4):187-201. PubMed ID: 14668691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update on endoscopic management of malignant obstructive jaundice].
    Barinagarrementeria R
    Rev Gastroenterol Mex; 2005 Jul; 70 Suppl 1():95-106. PubMed ID: 17469413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center.
    Brandi G; Venturi M; Pantaleo MA; Ercolani G;
    Dig Liver Dis; 2016 Mar; 48(3):231-41. PubMed ID: 26769568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hilar cholangiocarcinoma: resectability and radicality after routine diagnostic imaging.
    Otto G; Romaneehsen B; Hoppe-Lotichius M; Bittinger F
    J Hepatobiliary Pancreat Surg; 2004; 11(5):310-8. PubMed ID: 15549429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumors of the gallbladder, bile ducts, and ampulla.
    Lillemoe KD
    Semin Gastrointest Dis; 2003 Oct; 14(4):208-21. PubMed ID: 14719771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal ultrasonography combined with percutaneous transhepatic cholangioscopy for the preoperative evaluation of longitudinal tumor extent in hilar cholangiocarcinoma.
    Kim HM; Park JY; Kim KS; Park MS; Kim MJ; Park YN; Bang S; Song SY; Chung JB; Park SW
    J Gastroenterol Hepatol; 2010 Feb; 25(2):286-92. PubMed ID: 19780880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of uracil-tegafur plus doxorubicin and prognostic factors in patients with unresectable biliary tract cancer.
    Furuse J; Okusaka T; Ohkawa S; Nagase M; Funakoshi A; Boku N; Yamao K; Yamaguchi T; Sato T
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):113-20. PubMed ID: 19404641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of staging on treatment of biliary carcinoma.
    Kremer B; Henne-Bruns D; Vogel I; Grimm H; Soehendra N
    Endoscopy; 1993 Jan; 25(1):92-9. PubMed ID: 7681001
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis of cholangiocarcinoma: a case series and literature review.
    Jabara B; Fargen KM; Beech S; Slakey DR
    J La State Med Soc; 2009; 161(2):89-94. PubMed ID: 19489389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.